EndoTime:黄体期子宫内膜的非分类时间估算方法
基于尿液排卵检测的黄体期子宫内膜活检时间估算,通过测量IL2RB、IGFBP1、CXCL14、DPP4、GPX3和SLC15A2六个基因的表达,并采用连续非分类建模方法,可显著提高时间估算准确性并评估每个样本的可靠性。
要点
- 六个基因(IL2RB、IGFBP1、CXCL14、DPP4、GPX3、SLC15A2)的表达水平足以获得更准确的时间估算。
- EndoTime方法在连续域上建模基因表达时间轮廓,并报告每个样本的更新时间估算。
- 复发性妊娠丢失或复发性种植失败患者与对照者的估算时间无显著差异。
核心结论
- 测量六个基因的表达水平足以获得显著更准确的时间估算,并评估每个样本时间估算的可靠性。
研究设计与样本
- 研究通过RTq-PCR在不同样本集中测量基因表达,共包含664份自报家庭排卵检测阳性后4-12天获得的子宫内膜活检样本。
- 另有36份子宫内膜样本同时通过RTq-PCR和RNA测序进行分析。
- 建立名为EndoTime的计算流程,对每个基因的时间轮廓建模并估算每个样本的时间,迭代优化时间轮廓和估算置信度。
主要发现
- 按EndoTime估算排序样本比按患者报告时间排序相同表达值,对保留基因产生更尖锐的时间表达轮廓(GPX3:P < 0.005;CXCL14:P < 2.7e-6;DPP4:P < 3.7e-13)。
- 基于RTq-PCR与RNA测序数据的同一样本集EndoTime估算之间Pearson相关性显示高度一致(P = 8.6e-10,R2 = 0.687)。
- 对照者与复发性妊娠丢失或复发性种植失败患者的估算时间无显著差异(P > 0.05)。
临床怎么用
- EndoTime是首个在连续域上检测黄体期子宫内膜样本时间状态的方法,可自由获取并共享数据和开源软件。
- EndoTime能够对黄体子宫内膜样本中任何基因进行准确的时间轮廓分析,适用于广泛的研究应用,并可能用于临床。
局限性
- 时间估算基于腺体基因表达,只有当其他子宫内膜细胞类型与上皮同步时才能代表其时间状态。
- 仍需要估算排卵日的方法,因为这些数据是该方法的基本输入。
- 当前版本的方法进行批次校正,使得较大的样本批次对时间估算的准确性贡献更大。
- 理论上方法需要黄体期不同天数获得的子宫内膜样本;实践中基于尿液排卵检测的时间具有足够噪声以确保采样到不同时间点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can the accuracy of timing of luteal phase endometrial biopsies based on urinary ovulation testing be improved by measuring the expression of a small number of genes and a continuous, non-categorical modelling approach? SUMMARY ANSWER: Measuring the expression levels of six genes (IL2RB, IGFBP1, CXCL14, DPP4, GPX3 and SLC15A2) is sufficient to obtain substantially more accurate timing estimates and to assess the reliability of timing estimates for each sample. WHAT IS KNOWN ALREADY: Commercially available endometrial timing approaches based on gene expression require large gene sets and use a categorical approach that classifies samples as pre-receptive, receptive or post-receptive. STUDY DESIGN, SIZE, DURATION: Gene expression was measured by RTq-PCR in different sample sets, comprising a total of 664 endometrial biopsies obtained 4-12 days after a self-reported positive home ovulation test. A further 36 endometrial samples were profiled by RTq-PCR as well as RNA-sequencing. PARTICIPANTS/MATERIALS, SETTING, METHODS: A computational procedure, named 'EndoTime', was established that models the temporal profile of each gene and estimates the timing of each sample. Iterating these steps, temporal profiles are gradually refined as sample timings are being updated, and confidence in timing estimates is increased. After convergence, the method reports updated timing estimates for each sample while preserving the overall distribution of time points. MAIN RESULTS AND THE ROLE OF CHANCE: The Wilcoxon rank-sum test was used to confirm that ordering samples by EndoTime estimates yields sharper temporal expression profiles for held-out genes (not used when determining sample timings) than ordering the same expression values by patient-reported times (GPX3: P < 0.005; CXCL14: P < 2.7e-6; DPP4: P < 3.7e-13). Pearson correlation between EndoTime estimates for the same sample set but based on RTq-PCR or RNA-sequencing data showed a high degree of congruency between the two (P = 8.6e-10, R2 = 0.687). Estimated timings did not differ significantly between control subjects and patients with recurrent pregnancy loss or recurrent implantation failure (P > 0.05). LARGE SCALE DATA: The RTq-PCR data files are available via the GitHub repository for the EndoTime software at https://github.com/AE-Mitchell/EndoTime, as is the code used for pre-processing of RTq-PCR data. The RNA-sequencing data are available on GEO (accession GSE180485). LIMITATIONS, REASONS FOR CAUTION: Timing estimates are informed by glandular gene expression and will only represent the temporal state of other endometrial cell types if in synchrony with the epithelium. Methods that estimate the day of ovulation are still required as these data are essential inputs in our method. Our approach, in its current iteration, performs batch correction such that larger sample batches impart greater accuracy to timing estimations. In theory, our method requires endometrial samples obtained at different days in the luteal phase. In practice, however, this is not a concern as timings based on urinary ovulation testing are associated with a sufficient level of noise to ensure that a variety of time points will be sampled. WIDER IMPLICATIONS OF THE FINDINGS: Our method is the first to assay the temporal state of luteal-phase endometrial samples on a continuous domain. It is freely available with fully shared data and open-source software. EndoTime enables accurate temporal profiling of any gene in luteal endometrial samples for a wide range of research applications and, potentially, clinical use. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by a Wellcome Trust Investigator Award (Grant/Award Number: 212233/Z/18/Z) and the Tommy's National Miscarriage Research Centre. None of the authors have any competing interests. J.L. was funded by the Biotechnology and Biological Sciences Research Council (UK) through the Midlands Integrative Biology Training Partnership (MIBTP, BB/M01116X/1).
引用
- Lipecki J, Mitchell AE, Muter J, et al. EndoTime: non-categorical timing estimates for luteal endometrium. Hum Reprod. 2022. PMID: 35092277. doi:10.1093/humrep/deac006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。